Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Myosin, a structural component of muscle, consists of two heavy chains and four light chains. Additionally we are shipping Myosin Regulatory Light Chain 2, Smooth Muscle Isoform Kits (20) and Myosin Regulatory Light Chain 2, Smooth Muscle Isoform Proteins (11) and many more products for this protein.
Showing 10 out of 107 products:
Human Polyclonal MYL9 Primary Antibody for EIA, WB - ABIN953573
Gilles, Bluteau, Boukour, Chang, Zhang, Robert, Dessen, Debili, Bernard, Vainchenker, Raslova: MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9. in Blood 2009
Show all 5 references for 953573
Dog (Canine) Polyclonal MYL9 Primary Antibody for IF (p), IHC (p) - ABIN872283
Ikemura, Yamamoto, Motomura, Yamaguchi, Zhao, Iwasaki, Iwamoto: Preventive effects of the anti-vasospasm agent via the regulation of the Rho-kinase pathway on the development of steroid-induced osteonecrosis in rabbits. in Bone 2013
Show all 3 references for 872283
Cow (Bovine) Polyclonal MYL9 Primary Antibody for WB - ABIN2783319
Szczesna-Cordary, Guzman, Zhao, Hernandez, Wei, Diaz-Perez: The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice. in Journal of cell science 2005
Bird (Avian) Polyclonal MYL9 Primary Antibody for EIA, WB - ABIN318865
Nobe, Nobe, Fazal, De Lanerolle, Paul: Rho kinase mediates serum-induced contraction in fibroblast fibers independent of myosin LC20 phosphorylation. in American journal of physiology. Cell physiology 2003
Myosin phosphatase and cofilin mediate cAMP/cAMP-dependent protein kinase-induced decline in endothelial cell isometric tension and myosin II regulatory light chain phosphorylation
Myosin II may ordinarily move anteriorly on actin filaments and pull crossed filaments into antiparallel bundles, with the resulting realignment pulling the cell body forward.
MYL9 expression might be a promising prognostic marker and therapeutic target in ESCC
At the cleavage furrow Arv1 (show ARV1 Antibodies) recruits myosin heavy chain 9 (MYH9 (show MYH9 Antibodies)) and myosin light chain 9 (MYL9) by interacting with IQ-motif-containing GTPase-activating protein (show RASA1 Antibodies) (IQGAP1 (show IQGAP1 Antibodies)).
These findings suggested that low MYLK (show MYLK Antibodies) and MYL9 expressions might be associated with the development of NSCLC.
the decreased expression of MYL9 may play an important role in tumor progression of prostate cancer
Overexpression of MRTF-A (show MKL1 Antibodies) significantly promoted the migration of MCF-7 cells through its transactivation effects on MYL9 and CYR61 (show CYR61 Antibodies) genes
Overexpression of SMYD3 (show SMYD3 Antibodies) promotes MRTF-A (show MKL1 Antibodies)-mediated upregulation of MYL9 and migration of MCF-7 breast cancer cells
surface CD3 (show CD3 Antibodies) expression proceeds through both MYL9-dependent and MYL9-independent pathways (i.e. the protein kinase C (show PKC Antibodies)- dependent pathway) in Jurkat cells.
Endogenous Nogo-B (show RTN4 Antibodies), which may exert its effects through ARPC 2 (show ARPC2 Antibodies)/3 and MYL-9, is necessary for the migration and contraction of airway smooth muscle cells.
The FHC (show FTH1 Antibodies)-mediated structural perturbations in RLC that affect Ca(2 (show CA2 Antibodies)+) binding properties of mutated myocardium are responsible for triggering the abnormal function of the heart that in turn might initiate a hypertrophic process and lead to heart failure.
Smooth muscle type isoform, MLC-2C, is the inducible isoform, and might play a crucial role in monocyte/macrophage cell lineage.
Myosin, a structural component of muscle, consists of two heavy chains and four light chains. The protein encoded by this gene is a myosin light chain that may regulate muscle contraction by modulating the ATPase activity of myosin heads. The encoded protein binds calcium and is activated by myosin light chain kinase. Two transcript variants encoding different isoforms have been found for this gene.
Myosin regulatory light chain 2, smooth muscle isoform
, fast skeletal myosin light chain 2
, myosin regulatory light chain 2, smooth muscle isoform
, myosin regulatory light chain 9
, myosin regulatory light chain MRCL3
, myosin regulatory light polypeptide 9
, 20 kDa myosin light chain
, myosin RLC
, myosin regulatory light chain 1
, myosin regulatory light chain MRLC1
, myosin, light polypeptide 9, regulatory
, isoform L20-A
, light polypeptide 9
, myosin light chain 2
, myosin regulatory light chain 2, smooth muscle major isoform
, smooth muscle major isoform
, myosin, light chain 9, regulatory
, uncharacterized protein LOC450006
, myosin light chain, regulatory C